Get startedLog in
    Picture of Apellis Pharmaceuticals logo

    APLS — Apellis Pharmaceuticals News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareAdventurousLarge CapHigh Flyer
    All News

    Brief: Apellis Pharmaceuticals Q4 Basic EPS USD -0.29

    Picture of Apellis Pharmaceuticals logoApellis Pharmaceuticals
    28/02/2025 12:05
    Feb 28 (Reuters) - Apellis Pharmaceuticals Q4 net income USD -36.353 million.

Q4 product revenue USD 191.172 million

Q4 operating expenses USD 238.692 million

    Recent news on Apellis Pharmaceuticals

    See all news